- Lilly’s Mounjaro more popular than Wegovy in UK’s private obesity drug market Reuters.com
- England to roll out new anti-obesity drug but only for some patients Euronews
- UK to limit access to Lilly’s Zepbound; VivaVision’s positive Phase 2 Endpoints News
- How does weight loss drug Mounjaro work and why is it in such high demand? The Guardian
- Pharmalittle: We’re reading about U.K. restricting Lilly’s obesity drug, pharma layoffs, and more STAT
